A detailed history of Harbor Capital Advisors, Inc. transactions in Atri Cure, Inc. stock. As of the latest transaction made, Harbor Capital Advisors, Inc. holds 28,388 shares of ATRC stock, worth $948,159. This represents 0.04% of its overall portfolio holdings.

Number of Shares
28,388
Holding current value
$948,159
% of portfolio
0.04%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 14, 2025

BUY
$30.4 - $42.4 $862,995 - $1.2 Million
28,388 New
28,388 $916,000
Q4 2023

Jan 08, 2024

BUY
$32.99 - $43.25 $44,668 - $58,560
1,354 Added 6.47%
22,290 $795,000
Q3 2023

Oct 20, 2023

BUY
$41.12 - $57.73 $126,896 - $178,154
3,086 Added 17.29%
20,936 $916,000
Q2 2023

Jul 11, 2023

BUY
$40.44 - $49.6 $721,854 - $885,360
17,850 New
17,850 $881,000

Others Institutions Holding ATRC

About AtriCure, Inc.


  • Ticker ATRC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 46,424,700
  • Market Cap $1.55B
  • Description
  • AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...
More about ATRC
Track This Portfolio

Track Harbor Capital Advisors, Inc. Portfolio

Follow Harbor Capital Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbor Capital Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Harbor Capital Advisors, Inc. with notifications on news.